As the healthcare landscape continues to evolve, the pharmaceutical industry must adapt to the shifting dynamics that are shaping its future. From increased need for specialty treatments, to permanent change in HCP engagement preference, to the growing importance of patient voice, there have been numerous challenges for the industry in 2023. And despite these, the market grew in value by 11% last year.
Did you know that innovative biologics surged in value last year, with triple the growth of innovative small molecules?
Join us and get the answers, as we provide a first view of key pharma metrics for 2023, assess the current state of post-pandemic recovery, and give an outlook on what lies ahead in 2024.
In this webinar we will:
Analyze industry leading sales and medical data in a standardized and comparable way, including cross-country analysis of performance and additional insights into global and regional markets.
.svg){kind=icon}
